Hi GD, I'm not with you.... both the relenza & inavir studies involved families.
If indeed we are comparing apples with apples, then inavir results in lower infection rates than relenza while the placebo results are a bit out of whack.
Its got me why they cant try to register inavir for preventative indications with these results...
